Marc Lacroix (Marc.Lacroix@ulb.ac.be) is a biochemist and a researcher (b: April 28, 1963 in Verviers, Wallonia, Belgium) who specializes in breast cancer biology, metastasis and therapy.
He worked successively at the University of Liege (ULG), the Jules Bordet Institute and the Free University of Brussels (ULB).
He has published many scientific articles, including:
Lacroix, M; Leclercq G. (2004). "Relevance of breast cancer cell lines as models for breast tumours: an update". Breast Cancer Research and Treatment 83: 249 - 289.
Lacroix, M; Toillon RA, Leclercq G. (2004). "Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics". Endocrine-Related Cancer 11: 497 - 522.
Lacroix, M; Leclercq G, on behalf of BreastMed Consortium. (2005). "The "portrait" of hereditary breast cancer". Breast Cancer Research and Treatment 89: 297 - 304.
Lacroix, M; Toillon RA, Leclercq G. (2006). "P53 and breast cancer, an update". Endocrine-Related Cancer 13: 293 - 325.
Lacroix, M (2006). "Significance, detection and markers of disseminated breast cancer cells". Endocrine-Related Cancer 13: 1033-1067.
Lacroix, M (2008). "Persistent use of false cell lines". International Journal of Cancer 122: 1-4.
Marc.Lacroix@ulb.ac.be